Skip to main content
. 2017 Nov 17;2017(11):CD005067. doi: 10.1002/14651858.CD005067.pub4

Comparison 59.

IL zinc 2% (twice a week for 2 weeks) versus ILSSG (100 mg/mL) for 2 weeks)

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Lesions cured 1 Risk Ratio (M‐H, Random, 95% CI) Totals not selected